Tech earnings aplenty fueled Monday's after-hours session, and leading the way was a surging Apple ( AAPL). The Cupertino, Calif.-based computer giant said it earned $904 million, or $1.01 a share, in the third quarter -- a 62.9% per-share leap from last year -- on 28.5% higher revenue of $6.22 billion. Analysts polled by Thomson Financial were looking for 86 cents a share, less special items, on sales of $6.07 billion. Shares ramped up $12.95, or 7.4%, to $187.31. Online movie rental shop Netflix ( NFLX) jumped 13.4% after non-GAAP income vaulted 23.8% year-over-year to 26 cents a share. That powers past the 15-cent per-share target. Sales, at $294 million, were also higher than expected. The Los Gatos, Calif., company also said its subscriber base grew 24% from last year and 4% sequentially to some 7 million customers. It upped its fourth-quarter and full-year guidance. Shares were adding $3.09 to $26.10. Fellow tech name Zoran ( ZRAN) posted earnings of 26 cents a share on $146.4 million in sales, which sails past expectations of 39 cents a share on revenue of $138.5 million. Shares of the Sunnyvale, Calif., chipmaker recently were up 4.5% to $21.80. The financial sector also offered up a late winner in American Express ( AXP), which climbed 3% on positive third-quarter results . The charge- and credit-card company said continuing-operations earnings climbed 18.4% to 90 cents a share, or $1.07 billion. Analysts had forecast income of 85 cents a share. Shares were trading at $58.60 after-hours. But Texas Instruments ( TXN) slid 3.7% after the Dallas-based chipmaker forecast below-par fourth-quarter sales of between $3.4 billion and $3.68 billion. On average, the Street is seeking $3.71 billion. TI also predicted in-line fourth-quarter income and beat third-quarter estimates by 2 cents a share, but its stock was still off $1.27 at $33. Similarly, Pactiv ( PTV) beat third-quarter earnings estimates by a penny a share, but tumbled 7.2% to $26.80 on a disappointing outlook. The Lake Forest, Ill.-based packaging maker trimmed its full-year projection to between $1.80 to $1.84 a share vs. the prior range of between $1.82 to $1.92 a share. Analysts peg income at $1.88 a share. And Exact Sciences ( EXAS) widened its third-quarter loss to $3.6 million, or 13 cents a share, from 12 cents a share last year. The Marlborough, Mass., company blames this on $600,000 in restructuring costs, as well as lower non-cash license fee amortization due to an extended exclusivity period in its license with Laboratory Corporation of America. Shares of the applied genomics company were down 10.9% to $3.61 in light trading.